Skip To Main Content

Search

For optimal search results, please limit to 2 product keywords

If you are searching for information related to a product:

  • For optimal results, please enter at least 2 search terms in addition to product name
  • Example: [product name] [search term] [search term]
  • Example: Product + clinical trials
  • For an exact match, please include search terms in double quotations. For example: "health equity"

    Please enter search terms.

    Our Oncology Portfolio

    Find product and prescribing information, as well as other resources, for Genentech’s oncology portfolio below.

    A

    Alecensa®

    (alectinib)

    View Product Page

    Avastin®

    (bevacizumab)

    Prescribing Information

    Safety Data Sheets:

    AVASTIN® Vials (100 mg)
    AVASTIN® Vials (400 mg)

    Healthcare Provider Letters:

    Important Drug Warning: Necrotizing Fasciitis - Apr 2013
    Warning for Counterfeit Product Labeled as Avastin in the United States Feb 2012
    Important Change to Avastin® label for treatment of metastatic breast cancer - Nov 2011
    Important New Safety Information in Women Receiving AVASTIN - Oct 2011
    Intraocular Inflammatory Reactions - Dec 2008
    Microangiopathic Hemolytic Anemia (MAHA) - July 2008
    Tracheoesophageal (TE) Fistula - April 2007
    Cases of RPLS in Patients Receiving AVASTIN - Sept 2006
    VEGF antibodies for the treatment of retinopathy of prematurity - Aug 2006

    C

    Columvi®

    (glofitamab-gxbm)

    View Product Page

    Cotellic®

    (cobimetinib)

    Prescribing Information
    Important Patient Information

    Safety Data Sheets:

    COTELLIC Tablets (20 mg)

    E

    Erivedge®

    (vismodegib)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    ERIVEDGE® Capsules (150 mg)

    Healthcare Provider Letters:

    Important Drug Warning - November 2016
    Serious Risk with Use of Erivedge (vismodegib) Capsules: Premature Epiphyseal Fusion - June 2016
    Extension of Pregnancy Prevention Duration for Women of Childbearing Potential and Waiting Periods for Blood Donations and Lactation in Patients taking ERIVEDGE (vismodegib) capsule - February 2016

    G

    Gazyva®

    (obinutuzumab)

    Prescribing Information

    Safety Data Sheets:

    GAZYVA® Vials (1000 mg/40 mL)

    Healthcare Provider Letter:

    Gazyva™ (obinutuzumab) Important Drug Warning: Thrombocytopenia - Feb 2014

    H

    Herceptin®

    (trastuzumab)

    Prescribing Information

    Safety Data Sheets:

    HERCEPTIN® Vials (150 mg)

    Healthcare Provider Letters:

    440mg Vials and Herceptin BWFI Diluent - June 2008
    Updated Cardiotoxicity Information - Aug 2005
    Fatal Embryo-Fetal Toxicity due to Herceptin Exposure During Pregnancy

    Herceptin Hylecta™

    (trastuzumab and hyaluronidase-oysk)

    Prescribing Information

    Safety Data Sheets:

    HERCEPTIN HYLECTA™ Vials (600 mg/5 mL)

    I

    Itovebi™

    (inavolisib)

    View Product Page

    K

    Kadcyla®

    (ado-trastuzumab emtansine)

    Prescribing Information

    Safety Data Sheets:

    KADCYLA® Lyophilized Powder in Vials (100 mg)
    KADCYLA® Lyophilized Powder in Vials (160 mg)
    KADCYLA® Solution

    Healthcare Provider Letters:

    Kadcyla Important Safety Warning: Hemorrhage - Nov 2013
    KADCYLA (ado-trastuzumab emtansine) error on the carton - May 2013

    L

    Lunsumio®

    (mosunetuzumab-axgb)

    View Product Page

    P

    Perjeta®

    (pertuzumab)

    Prescribing Information

    Safety Data Sheets:

    PERJETA® (420 mg)

    Phesgo®

    (pertuzumab, trastuzumab, and hyaluronidase-zzxf)

    Prescribing Information

    Safety Data Sheets:

    PHESGO® (pertuzumab, trastuzumab & hyaluronidase-zzxf) Injection (60 mg/mL, 60 mg/mL)
    PHESGO® (pertuzumab, trastuzumab & hyaluronidase-zzxf) Injection (80 mg/mL, 40 mg/mL)

    Polivy®

    (polatuzumab vedotin-piiq)

    View Product Page

    R

    Rituxan®

    (rituximab)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    RITUXAN® Vials (100 mg/10 mL)
    RITUXAN® Vials (500 mg/50 mL)

    Healthcare Provider Letters:

    Rituxan® (rituximab) Label: Hepatitis B Reactivation - October 2013
    Important Drug Warning: Updated Safety Information - Dec 2006
    Important Drug Warning: New Safety Information - Sept 2008
    Important Drug Warning: Updated Safety Information - Oct 2009

    Rituxan Hycela®

    (rituximab and hyaluronidase human)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    RITUXAN HYCELA® Vials (1600 mg)
    RITUXAN HYCELA® Vials (1400 mg)

    Rozlytrek®

    (entrectinib)

    Prescribing Information
    Important Patient Information

    Safety Data Sheets:

    ROZLYTREK® Capsules (100 mg)
    ROZLYTREK® Capsules (200 mg)

    T

    Tecentriq®

    (atezolizumab)

    View Product Page

    Tecentriq Hybreza™

    (atezolizumab and hyaluronidase-tqjs)

    View Product Page

    V

    Venclexta®

    (venetoclax)

    View Product Page

    X

    Xeloda®

    (capecitabine)

    Prescribing Information
    Important Patient Information

    Safety Data Sheets:

    XELODA® Tablets (150 mg)
    XELODA® Tablets (500 mg)

    Z

    Zelboraf®

    (vemurafenib)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    ZELBORAF® F.C. Tablets (240 mg)

    Healthcare Provider Letters:

    Important Drug Warning - June 2017
    Important Drug Warning - March 2014
    Important Drug Warning - August 2013
    Publications icon

    Publications

    Visit PubMed.gov to view scientific literature for Genentech oncology portfolio products.

    Avastin® at PubMed.gov

    Cotellic® at PubMed.gov

    Erivedge® at PubMed.gov

    Gazyva® at PubMed.gov

    Herceptin® at PubMed.gov

    Kadcyla® at PubMed.gov

    Perjeta® at PubMed.gov

    Phesgo® at PubMed.gov

    Rituxan® at PubMed.gov

    Rozlytrek® at PubMed.gov

    Xeloda® at PubMed.gov

    Zelboraf® at PubMed.gov

    Scientific congresses icon

    Scientific Congresses

    Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

    Clinical trials icon

    Clinical Trials

    Find information about active clinical research for Genentech oncology portfolio products.

    Avastin® at ClinicalTrials.gov

    Cotellic® at ClinicalTrials.gov

    Erivedge® at ClinicalTrials.gov

    Gazyva® at ClinicalTrials.gov

    Herceptin® at ClinicalTrials.gov

    Kadcyla® at ClinicalTrials.gov

    Perjeta® at ClinicalTrials.gov

    Phesgo® at ClinicalTrials.gov

    Rituxan® at ClinicalTrials.gov

    Rozlytrek® at ClinicalTrials.gov

    Xeloda® at ClinicalTrials.gov

    Zelboraf® at ClinicalTrials.gov

    Additional resources icon

    Additional Resources

    Connect with a Medical Science Liaison

    Browse the Genentech Medical Information Library